相关实验视频
Updated: Jun 16, 2025

Viability Assays for Cells in Culture
Published on: January 20, 2014
抑制单胺氧化酶和神经保护作用:石英与染色体对比
Reshma Ipe1, Jong Min Oh2, Sunil Kumar1
1Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, AIMS Health Sciences Campus, Amrita Vishwa Vidyapeetham, Kochi, 682041, India.
这项研究合成了新型的 (HC) 和染色体 (HF) 化合物,确定HC4作为一种强有力的MAO-B抑制剂,HF4作为一种选择性的MAO-A抑制剂. 这两种化合物都表现出对罗诺诱导毒性的神经保护作用,这表明神经系统疾病的潜在治疗应用.
科学领域:
- 药用化学 医学化学
- 神经科学是一个神经科学.
- 生物化学 生物化学
背景情况:
- 单胺氧化酶 (MAO) 酶是治疗诸如帕金森病和阿尔茨海默病等神经系统疾病的关键标.
- 开发具有神经保护性质的选择性MAO抑制剂是一个重要的治疗目标.
研究的目的:
- 为了合成和评估新的 (HC) 和染色体 (HF) 衍生物,以检测它们对MAO-A和MAO-B的抑制活性.
- 研究化合物的神经保护潜力,以防止罗农诱导的神经毒性.
主要方法:
- 在两个系列 (HC1-HC9和HF1-HF9) 中合成了18种化合物.
- 在体外酶抑制试验测试以确定IC50值和选择性指数 (SI).
- 酶动力学,可逆性研究,分子对接和动态模拟.
- 在体内评估神经保护,使用罗农诱导的神经毒性模型 (ROS和SOD试验,线粒体膜潜力).
主要成果:
- (HC) 衍生物显示出更高的MAO-B抑制,HC4是最强的 (IC50 = 0.040μM).
- 染色体 (HF) 衍生物表现出偏好的MAO-A抑制,HF4是最强的 (IC50 = 0.046μM).
- HC4和HF4显示出显著的神经保护作用,防止罗诺诱导的毒性,维护线粒体功能和减少氧化应激.
结论:
- HC4是一种强效和选择性的MAO-B抑制剂,而HF4是一种强效的MAO-A抑制剂.
- 在B环的4位置的乙氧基替代显著增强了基 (HC4) 中的MAO-B抑制和染色体 (HF4) 中的MAO-A抑制.
- 由于其MAO抑制和神经保护作用,HC4和HF4都显示出作为神经疾病治疗剂的前景.
更多相关视频
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
10:13Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
Published on: July 31, 2017
相关概念视频
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Cholinergic Antagonists: Pharmacological Actions
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Drugs Affecting Neurotransmitter Synthesis
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...